16-4340913-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The ENST00000318059.8(PAM16):c.291+7G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00558 in 1,612,938 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
ENST00000318059.8 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAM16 | NM_016069.11 | c.291+7G>T | splice_region_variant, intron_variant | ENST00000318059.8 | NP_057153.8 | |||
CORO7-PAM16 | NM_001201479.2 | c.3060+7G>T | splice_region_variant, intron_variant | NP_001188408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAM16 | ENST00000318059.8 | c.291+7G>T | splice_region_variant, intron_variant | 1 | NM_016069.11 | ENSP00000315693 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00423 AC: 644AN: 152094Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00390 AC: 979AN: 250954Hom.: 3 AF XY: 0.00395 AC XY: 536AN XY: 135778
GnomAD4 exome AF: 0.00572 AC: 8354AN: 1460728Hom.: 35 Cov.: 32 AF XY: 0.00558 AC XY: 4051AN XY: 726614
GnomAD4 genome AF: 0.00422 AC: 643AN: 152210Hom.: 1 Cov.: 33 AF XY: 0.00369 AC XY: 275AN XY: 74438
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PAM16: BP4, BS2 - |
PAM16-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at